openPR Logo
Press release

L-Hydroxyphenylalanine Market is Poised to Exhibit A Moderate 3.5% CAGR through 2018 to 2028

10-16-2018 11:04 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

L-Hydroxyphenylalanine Market is Poised to Exhibit A Moderate

As a part of the amino acid family, use of L-hydroxyphenylalanine as an energy providing aromatic ingredient has significantly fuelled its demand across the dietary supplement and nutraceuticals space. This factor continues to remain instrumental in driving the growth of the L-hydroxyphenylalanine market during the period of forecast. Moreover, various pharmaceutical uses of L-hydroxyphenylalanine including its application in formulations to treat Parkinson’s disease, Alzheimer’s disease and cancer are also expected to contribute to the overall growth of the L-hydroxyphenylalanine market. Being recognized as GRAS (Generally Recognized as Safe) by the FDA, the use of L-hydroxyphenylalanine in food and beverage sector has also witnessed significant growth in recent times.

A new research study by Fact.MR reveals growth pathways for L-hydroxyphenylalanine from a global viewpoint during the period of forecast, 2018-2028. The report includes estimations that reflect global sales of L-hydroxyphenylalanine which are expected to cross US$ 1,500 Mn by end of the year of assessment (2028). The sales of L-hydroxyphenylalanine are expected to remain concentrated in the developed countries of North America and emerging economies in the Asia Pacific excluding Japan (APEJ) region, given the increasing demand for L-hydroxyphenylalanine in anti-ageing creams and as effective adjuvant in cancer treatment in these regions.

You can Get Free Sample Report Here @ https://www.factmr.com/connectus/sample?flag=S&rep_id=918 

L-Hydroxyphenylalanine Market: Use of L-Hydroxyphenylalanine in Dietary Supplements to Spearhead in the Coming Years

Dietary supplements and nutraceuticals have witnessed significant proliferation across various countries worldwide, given the increasing consumer awareness regarding healthy diet and exercise. Moreover, the growing number of individuals participating in heavy physical activities has further complemented the use of supplements for enhancing muscle growth. Being an amino acid, L-hydroxyphenylalanine as an energy ingredient has witnessed high demand in the production of health supplements, which is expected to fuel the growth of the L-hydroxyphenylalanine market during the period of forecast.

L-Hydroxyphenylalanine Market: High Prevalence of Parkinson’s Disease to Call for Efficient Treatment Solutions

Parkinson’s disease is directly associated with low blood pressure and orthostatic hypotension, that translates into need for effective pharmaceutical formulations that facilitate high energy flow and increase the heart rate. That said, L-hydroxyphenylalanine plays an imperative role in producing significant amount of energy that improves parkinsonian orthostatic hypotension and raises blood pressure, causing the shaking of body to reduce drastically. This factor coupled with increasing cases of Parkinson’s disease across the globe has enhanced the demand of L-hydroxyphenylalanine, in turn contributing to the growth of the L-hydroxyphenylalanine market during the period of forecast.

Report Analysis@ https://www.factmr.com/report/918/l-hydroxyphenylalanine-market 

L-Hydroxyphenylalanine Market: Melanoma Treatment to Create Potential Avenues

Treatment of melanoma is expected to pave significant pathways for growth of the L-hydroxyphenylalanine market, as studies reveal the potential of the L-hydroxyphenylalanine in production of melanin. The Federation of American Societies for Experimental Biology Journal has highlighted the link between mitochondrial function and production of melanin in cancerous skin cells. Post examination revealed that the rate of Reactive Oxygen Species generation in darker cells were high as compared to medium and low level pigments. Provision of L-hydroxyphenylalanine as a building block for melanin production, has been used to activate medium and light cells to increase the production of melanin. This concept is expected to trigger coupling cellular adaptation and stress signaling through ROS signaling, which in turn has the potential to support development of anti-cancer drugs for treating melanoma. This approach is expected provide substantial growth opportunities for the use L-hydroxyphenylalanine, consequently fuelling the growth of the L-hydroxyphenylalanine market during the forecast period.

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Follow us in Linkedin: https://www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release L-Hydroxyphenylalanine Market is Poised to Exhibit A Moderate 3.5% CAGR through 2018 to 2028 here

News-ID: 1306216 • Views:

More Releases from Fact.MR

European Chicory Root Fiber Market Outlook 2025-2035: Key Developments and Future Scope
11-19-2025 | Food & Beverage
Fact.MR
European Chicory Root Fiber Market Outlook 2025-2035: Key Developments and Futur …
The global chicory root fiber market is projected to expand significantly over the next decade, driven by increasing demand for prebiotic dietary fibers, clean-label ingredients, and functional food formulations. The market is estimated to grow from USD 1.1 billion in 2025 to around USD 1.85 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.3%. Key Market Highlights 2025 Market Value: USD 1,100.0 million 2035 Forecast Value: USD 1,850.0 million Projected CAGR
European Refillable Packaging Market Forecast 2025-2035: Trends and Growth Insights
European Refillable Packaging Market Forecast 2025-2035: Trends and Growth Insig …
The global refillable packaging market is projected to expand significantly over the next decade, as businesses and consumers shift toward circular and sustainable packaging solutions. From an estimated USD 47.5 billion in 2025, the market is expected to reach approximately USD 75.0 billion by 2035, reflecting a compound annual growth rate (CAGR) of 4.7%. Key Market Insights 2025 Market Value: USD 47.49 billion 2035 Forecast Value: USD 75.01 billion Projected CAGR (2025-2035): 4.7% Leading Packaging
European Portable Power Station Market Outlook 2025-2035: Innovation, Growth, and Demand Trends
European Portable Power Station Market Outlook 2025-2035: Innovation, Growth, an …
The global portable power station market is set for explosive growth over the next decade, driven by rising demand for reliable, off-grid energy solutions in both residential and commercial settings. According to recent market research, the market is projected to increase from USD 4.2 billion in 2025 to USD 30.3 billion by 2035, representing a compound annual growth rate (CAGR) of 21.8%. Key Market Highlights: 2025 Market Value: USD 4.2 billion 2035 Forecast
European Liquid Soap Market Outlook (2025-2035): Key Developments & Future Scope
European Liquid Soap Market Outlook (2025-2035): Key Developments & Future Scope
The European liquid soap market is poised for consistent, value-driven growth from 2025 to 2035, supported by sustained hygiene awareness, rising adoption of natural and dermatologically advanced formulations, and rapid expansion of refillable and sustainable packaging systems. As consumers shift from traditional bar soaps to premium liquid soap formats, manufacturers across Europe are entering a period of accelerated innovation and competitive differentiation. Market Outlook (2025-2035) The European liquid soap market is expected

All 5 Releases


More Releases for Parkinson’s

Parkinson’s Disease Treatment Market 2021 | Detailed Report
Parkinson’s Disease Treatment Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Get Free Sample PDF (including full TOC, Tables and Figures) of Parkinsons Disease Treatment Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5024082 The report provides a comprehensive analysis of company profiles listed below: - Teva - Roche - Prothena - Acorda
Parkinson’s Disease Treatment Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Parkinson’s Disease Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Parkinson’s Disease Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Parkinson’s Disease Treatment with respect
US Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds
Europe Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been estimated that currently, more than 1 million in Europe are affected by Parkinson’s disease. This figure is most likely to double by 2030. Among the most common neurodegenerative disease (after Alzheimer’s disease), Parkinson’s is the second most common and it is expected that
Parkinson’s Disease - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Parkinson’s Disease - Heat Map and Analysis to its growing collection of premium market research reports. Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties,
New Education Options for Parkinson’s Caregivers
(4/30/2012- Gilbert, Ariz.) When a loved one is diagnosed with Parkinson’s Disease (PD), it becomes clear that Parkinson’s is a life- changing experience for the entire family — particularly for the primary care provider, who is most often a spouse, child or parent. Family caregivers may not think of themselves as a care providers or recognize their new caregiving tasks. As family members begin helping with doctor visits, taking over financial